NCT01520181 - Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Beta-lactam Allergy

Interventions

DRUG

Beta-lactam oral challenge

Oral daily dose, according to patient's weight, of amoxicillin or other suspected beta-lactam will be administered for 5 consecutive days

Trial Locations (1)

Arnon Goldberg, Allergy and Clinical Unit, Meir Medical Center, Kfar Saba